What is CITANEST PLAIN used for?

CITANEST PLAIN is an FDA-approved medication. See full prescribing information for approved uses.

Is CITANEST PLAIN FDA approved?

Yes, CITANEST PLAIN is FDA approved (first approved 1965-11-18) and manufactured by AstraZeneca.

Who makes CITANEST PLAIN?

CITANEST PLAIN is manufactured by AstraZeneca.

Data updated: Mar 10, 2026

CITANEST PLAIN

PRILOCAINE HYDROCHLORIDE

Approved 1965-11-18

Jump to: Indications Approvals Trials Competitors Safety Patents

Indication

Phase 3 Trials

Priority Reviews

Years on Market

Details

Status: Discontinued
First Approved: 1965-11-18
Routes: INJECTION
Dosage Forms: INJECTABLE

Companies

AstraZeneca

Active Ingredient: PRILOCAINE HYDROCHLORIDE

CITANEST PLAIN Approval History

Loading approval history...

What CITANEST PLAIN Treats

1 FDA approvals

Originally approved for its first indication in 1965 .

Other (1)

🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

Understanding FDA Approval Types

Count	Type	What it means
-	ORIG	Original approval - drug first enters market
-	SUPPL - Efficacy	New indication (new disease/condition approved)
-	SUPPL - Labeling	Label text changes (warnings, dosing updates)
-	SUPPL - Manufacturing	Production changes (new facility)
-	SUPPL - Chemistry	Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

CITANEST PLAIN FDA Label Details

Pro

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

FDA Approval: NDA014763 → Patents: FDA Orange Book → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.